NASDAQ: IRMDIradimed Corp Stock Ownership - Who owns Iradimed?
Insider buying vs selling
Have Iradimed Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Monty K. Allen | Director | 2025-08-06 | 1,102 | $69.10 | $76.15kSell |
| John Glenn | CHIEF FINANCIAL OFFICER | 2025-06-20 | 1,412 | $58.24 | $82.23kSell |
| John Glenn | CHIEF FINANCIAL OFFICER | 2024-12-02 | 2,500 | $54.18 | $135.45kSell |
| Anthony Vuoto | Director | 2024-11-06 | 2,690 | $55.99 | $150.62kSell |
IRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IRMD insiders and whales buy or sell their stock.
IRMD Shareholders
What type of owners hold Iradimed Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Roger E. Susi | 36.07% | 4,587,950 | $333.50M | Insider |
| Blackrock Inc | 7.57% | 962,341 | $69.95M | Institution |
| Nine Ten Capital Management LLC | 6.86% | 872,003 | $63.39M | Institution |
| Vanguard Group Inc | 4.41% | 561,032 | $40.78M | Institution |
| Renaissance Technologies LLC | 3.87% | 491,812 | $35.75M | Institution |
| Copeland Capital Management LLC | 3.60% | 457,919 | $33.29M | Institution |
| Geode Capital Management LLC | 2.05% | 261,386 | $19.00M | Institution |
| Serge Novovich | 1.92% | 244,636 | $17.78M | Insider |
| Dimensional Fund Advisors LP | 1.69% | 215,426 | $15.66M | Institution |
| Ranger Investment Management LP | 1.69% | 214,840 | $15.62M | Institution |
IRMD vs Medical Device Stocks
Iradimed Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.